Edgewise Therapeutics Inc. has announced the grant of inducement equity awards to nine new non-executive employees. The company has issued stock options to purchase a total of 247,000 shares at an exercise price of $16.22 per share, matching the closing price on the grant date of September 30, 2025. These options vest with 25% of the shares vesting after one year of employment, and the remainder vesting monthly over the following three years. Additionally, Edgewise granted restricted stock units (RSUs) covering 15,000 shares, which will vest in equal installments annually over four years.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA89418) on October 02, 2025, and is solely responsible for the information contained therein.